Senate Concurrent ResolutionChaptered/Signed
SCR 20: Peripartum Cardiomyopathy Awareness Month.
What SCR 20 does, verified December 13, 2025
This measure would designate February 2025 as Peripartum Cardiomyopathy Awareness Month. The purpose of this designation is to raise awareness about this rare but potentially life-threatening condition that affects some women during pregnancy or shortly after childbirth. By setting aside a specific month for awareness, the measure aims to educate healthcare providers, patients, and the general public about the condition, its symptoms, and available treatment options.
Bill journey
✓IntroducedComplete
✓In CommitteeComplete
✓First Chamber FloorComplete
✓Second ChamberComplete
✓GovernorComplete
6ChapteredCurrent
Last action: Chaptered by Secretary of State. Res. Chapter 27, Statutes of 2025. (2025-03-25)Alert me
Author and sponsors
Full contact details, staff, and committees with Connect, $16/moUnlockRecent actions7 total · showing 5
| Mar. 25, 2025 | Chaptered by Secretary of State. Res. Chapter 27, Statutes of 2025. |
| Mar. 20, 2025 | In Senate. Ordered to engrossing and enrolling. |
| Mar. 17, 2025 | From committee: Be adopted. Ordered to consent calendar. (Ayes 10. Noes 0.) (March 17). |
| Mar. 03, 2025 | Referred to Com. on RLS. |
| Feb. 27, 2025 | In Assembly. Held at Desk. |
Latest bill textChaptered version, March 25, 2025 · 566 words
Senate Concurrent Resolution No. 20
CHAPTER 27
Relative to Peripartum Cardiomyopathy Awareness Month.
[ Filed with Secretary of State March 25, 2025. ]
LEGISLATIVE COUNSEL'S DIGEST
SCR 20, Ochoa Bogh. Peripartum Cardiomyopathy Awareness Month.
This measure would designate February 2025 as Peripartum Cardiomyopathy Awareness Month.
WHEREAS, Peripartum cardiomyopathy (PPCM) is a form of heart failure that most often develops late in pregnancy but can occur up to five months into the postpartum period; and
WHEREAS, According to the New England Journal of Medicine, the incidence of PPCM varies from 1 in 100 to 1 in 300 pregnancies in “geographic hot spots,” such as Nigeria and Haiti, to 1 in 1,000 to 1 in 4,000 in Europe and the United States; and
WHEREAS, According to the federal Centers for Disease Control and Prevention, general cardiomyopathy was the cause of 9 percent of pregnancy-related deaths between 2017 and 2019, inclusive; and
WHEREAS, According to the American Heart Association, PPCM is diagnosed in mothers without a prior diagnosis of heart disease and when no other cause of heart failure can be found; and
WHEREAS, PPCM can cause fatigue and low blood pressure due to restricted blood flow and swelling due to fluid buildup around vital organs; and
WHEREAS, PPCM is difficult to diagnosis because symptoms mimic those of a healthy pregnancy, such as shortness of breath, increased urination at night, heart palpitations, swelling in the feet and legs, and lightheadedness; and
WHEREAS, A weight gain of three pounds or more over a day or two may signal a fluid buildup that warrants a conversation with a medical professional; and
WHEREAS, Several factors increase the risk of developing PPCM, including high blood pressure, preeclampsia, multiple gestations (e.g., twins), and advanced maternal age (e.g., 35 years of age or older); and
WHEREAS, PPCM is more common amongst mothers of color and mothers diagnosed with PPCM in past pregnancies; and
WHEREAS, According to the New England Journal of Medicine, some genetic mutationsincluding titin truncating variantsmay predispose some women to PPCM; and
WHEREAS, According to the American Heart Association, PPCM is diagnosed when three criteria are met: 1) heart failure develops in late pregnancy or within months following delivery; 2) left ventricular ejection fraction (the percentage of fluid ejected from the left ventricle) is less than 45 percent (typically measured by an echocardiogram); and 3) no other cause for this heart failure can be found; and
WHEREAS, Brain natriuretic peptide (BNP) and N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) levels may be tested to indicate to medical providers that the heart is not pumping properly; and
WHEREAS, If caught early, many women with PPCM will recover normal heart function within six months after treatment starts; and
WHEREAS, If left untreated, PPCM can lead to advanced, lifelong heart failure which could require a heart transplant or even result in death; and
WHEREAS, PPCM treatment can include common medications that lower blood pressure, improve heart function, or reduce fluid retention, or a combination of the three, and diet changes such as restricting fluid and salt; and
WHEREAS, Women can minimize their PPCM risk by not drinking or smoking, eating a well-balanced diet, exercising, and monitoring their blood pressure; now, therefore, be it
Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature proclaims the month of February 2025 as Peripartum Cardiomyopathy Awareness Month; and be it further
Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.
Text of SCR 20 as chaptered, from the official record. Connect Plus keeps every version and highlights what changed.Compare versions